CLINICAL PRESENTATION AND BACTERIOLOGICAL PROFILE OF ICU ADMITTED PATIENTS WITH VENTILATOR ASSOCIATED PNEUMONIA IN KHYBER TEACHING HOSPITAL PESHAWAR
Journal of Khyber College of Dentistry,
Journal Year:
2025,
Volume and Issue:
15(01), P. 38 - 43
Published: March 18, 2025
Objectives:
To
determine
bacteriological
profile
of
ICU
admitted
patients
with
ventilator
associated
pneumonia.Materials
and
Methods:
A
descriptive
cross-sectional
study
was
conducted
from
July
2018
to
April
2020
at
department
Medical
ICU.
total
172
were
observed
for
clinical
presentation
in
pneumonia.
Data
presented
form
frequency
percentages.The
p-value
less
than
0.05
considered
as
statistically
significant.Results:
Out
patients,
24
(13.71%)
18
(10.2%)
having
Diabetes
Mellitus
(DM)
Hypertension
(HTN),
respectively.
Patients
who
received
mechanical
ventilation
0-5
days
had
a
relatively
low
recovery
rate
8.8%,
the
majority
(91%)
unfortunately
expiring.
In
6–10-day
category,
there
slightly
higher
14.8%,
but
still,
(85%)
did
not
survive.
>16
ventilation,
show
(35.2%).
The
highest
number
bacteria
isolated
day’s
while
lowest
growth
6-10
ventilated
patients.
antibiotics
susceptibility,
are
variations
antibiotic
eff
ectiveness
across
different
bacterial
strains
antibiotics.
Fosfomycin
Tigecycline
ect
against
all
except
Acinobacter
baumannii
Colistin
effective
Pseudomonas.Conclusion:
on
lower
chances
early
days,
those
longer
showed
better
outcomes.
common
comorbidities.
Bacterial
ventilation.
Antibiotics
like
whereas
also
ective
all,
Pseudomonas.
Language: Английский
Legionnaires’ disease: A review of emerging public health threats
International Journal of One Health,
Journal Year:
2025,
Volume and Issue:
unknown, P. 62 - 77
Published: March 1, 2025
Background
and
Aim:
Legionnaires’
disease
(LD),
caused
by
the
Gram-negative
bacterium
Legionella
pneumophila,
has
emerged
as
a
significant
public
health
concern
due
to
its
rising
incidence
high
morbidity
mortality
rates.
This
review
comprehensively
examines
etiology,
epidemiology,
pathogenesis,
clinical
presentation,
diagnosis,
treatment,
prevention
of
LD.
The
thrives
in
aquatic
environments,
often
within
biofilms
protozoan
hosts,
contributing
resilience
widespread
distribution
natural
man-made
water
systems.
Transmission
primarily
occurs
through
inhalation
contaminated
aerosols,
with
immunocompromised
individuals,
elderly,
smokers
being
at
heightened
risk.
Clinically,
LD
presents
severe
pneumonia
systemic
involvement,
diagnosis
relies
on
culture,
urinary
antigen
tests,
molecular
methods.
treatment
landscape
is
dominated
macrolides
fluoroquinolones,
emerging
research
into
alternative
therapies
combat
antimicrobial
resistance.
Effective
strategies,
including
rigorous
management
practices
infection
control
measures,
are
vital
mitigating
risk
outbreaks.
aims
enhance
awareness
inform
initiatives
elucidating
complex
interplay
between
bacterial
virulence,
host
factors,
environmental
conditions
that
contribute
transmission
persistence.
A
better
understanding
these
dynamics
crucial
for
developing
robust
ultimately
reducing
global
burden
this
potentially
life-threatening
disease.
Keywords:
disease,
pneumonia,
health,
waterborne
pathogens.
Language: Английский
Bacterial Superinfections After SARS-CoV-2 Pneumonia: Antimicrobial Resistance Patterns, Impact on Inflammatory Profiles, Severity Scores, and Clinical Outcomes
Petrinela Daliu,
No information about this author
Iulia Bogdan,
No information about this author
Ovidiu Roşca
No information about this author
et al.
Diseases,
Journal Year:
2025,
Volume and Issue:
13(5), P. 145 - 145
Published: May 9, 2025
Background
and
Objectives:
Secondary
bacterial
pneumonia
can
substantially
worsen
the
clinical
trajectory
of
patients
hospitalized
for
Coronavirus
Disease
2019
(COVID-19).
This
study
aimed
to
characterize
superinfections
in
COVID-19,
including
pathogen
profiles,
resistance
patterns,
inflammatory
responses,
severity
scores,
ICU
admission
risk.
Methods:
In
a
retrospective
cohort
design,
we
reviewed
141
admitted
single
tertiary-care
hospital
between
February
2021
December
2024.
A
total
58
had
laboratory-confirmed
superinfection
by
sputum,
bronchoalveolar
lavage,
or
blood
cultures
(superinfection
group),
whereas
83
COVID-19
without
any
documented
pathogens
(COVID-only
group).
We
collected
detailed
microbiological
data
from
lavage
(BAL),
cultures.
Antibiotic
sensitivity
testing
was
performed
using
standard
breakpoints
multidrug
(MDR).
Inflammatory
markers
(C-reactive
protein,
procalcitonin,
neutrophil-to-lymphocyte
ratio,
systemic
immune-inflammation
index)
indices
Acute
Physiology
Chronic
Health
Evaluation
(APACHE)
II,
Confusion,
Urea,
Respiratory
rate,
Blood
pressure
(CURB),
National
Early
Warning
Score
(NEWS)
were
measured
at
admission.
Primary
outcomes
included
intensive
care
unit
(ICU)
admission,
mechanical
ventilation,
mortality.
Results:
Patients
group
showed
significantly
elevated
scores
compared
COVID-only
(mean
APACHE
II
17.2
vs.
13.8;
p
<
0.001).
Pathogens
most
frequently
isolated
sputum
BAL
Klebsiella
pneumoniae
(27.6%)
Pseudomonas
aeruginosa
(20.7%).
Multidrug-resistant
strains
32.8%
isolates.
The
higher
admissions
(37.9%
19.3%;
=
0.01)
more
frequent
ventilation
(25.9%
9.6%;
0.01).
Mortality
trended
among
superinfected
(15.5%
7.2%;
0.09).
34%
prior
antibiotic
use,
which
independently
predicted
MDR
(aOR
2.6,
presence
such
as
(OR
2.8),
2.5),
Staphylococcus
aureus
2.1)
increases
risk
Conclusions:
Bacterial
exacerbates
inflammation
worsens
patients,
Language: Английский